These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35836941)

  • 21. Charlson Comorbidity Index Predicts 5-Year Survivorship of Surgically Treated Hip Fracture Patients.
    Jiang L; Chou ACC; Nadkarni N; Ng CEQ; Chong YS; Howe TS; Koh JSB
    Geriatr Orthop Surg Rehabil; 2018; 9():2151459318806442. PubMed ID: 30479849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
    Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
    Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
    Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
    [No Abstract]   [Full Text] [Related]  

  • 24. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene.
    Roghmann F; von Bodman C; Löppenberg B; Hinkel A; Palisaar J; Noldus J
    BJU Int; 2012 Nov; 110(9):1359-65. PubMed ID: 22494217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Value of the Age-Adjusted Charlson Comorbidity Index for Outcomes After Hepatic Resection of Hepatocellular Carcinoma.
    Shinkawa H; Tanaka S; Takemura S; Amano R; Kimura K; Nishioka T; Miyazaki T; Kubo S
    World J Surg; 2020 Nov; 44(11):3901-3914. PubMed ID: 32651603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
    Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries.
    Dessai SB; Fasal R; Dipin J; Adarsh D; Balasubramanian S
    South Asian J Cancer; 2018; 7(4):240-243. PubMed ID: 30430092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
    Koppie TM; Serio AM; Vickers AJ; Vora K; Dalbagni G; Donat SM; Herr HW; Bochner BH
    Cancer; 2008 Jun; 112(11):2384-92. PubMed ID: 18404699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical re-evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults: Should we waive this treatment in certain patients?
    Van Coile L; Brochez L; Verhaeghe E; Boone B; Meertens A; Ongenae K; Hoorens I
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1792-1798. PubMed ID: 37147863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Charlson Comorbidity Index is correlated with all-cause readmission within six months in patients with heart failure: a retrospective cohort study in China.
    Sheng S; Xu FQ; Zhang YH; Huang Y
    BMC Cardiovasc Disord; 2023 Mar; 23(1):111. PubMed ID: 36879196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
    Dreyer J; Bremer M; Henkenberens C
    Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors.
    Takada Y; Kawashima H; Ohno E; Ishikawa T; Mizutani Y; Iida T; Yamamura T; Kakushima N; Furukawa K; Nakamura M; Honda T; Ishigami M; Ito A; Hirooka Y
    J Gastroenterol; 2022 Mar; 57(3):199-207. PubMed ID: 35098349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Index Admission Characteristics and All-Cause Readmissions Analysis in Younger and Older Adults with Intracerebral Hemorrhage.
    Kim BD; Kurian C; Stein LK; Tuhrim S; Dhamoon MS
    Cerebrovasc Dis; 2020; 49(4):375-381. PubMed ID: 32829328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Age and Comorbidity on Multimodal Management and Survival from Colorectal Cancer: A Population-Based Study.
    Kellokumpu I; Kairaluoma M; Mecklin JP; Kellokumpu H; Väyrynen V; Wirta EV; Sihvo E; Kuopio T; Seppälä TT
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
    Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
    BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
    Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.